ENTX Entera Bio Ltd.
$2.84▲ +1.79%
Healthcare
Other
After hours
$2.84▲ +0.00%
Sep 11, 7:30 PM ET
Volume 187.6K
Avg Volume (10D) 358.2K
Key Metrics & Fundamentals
Market Cap
$491.72M
P/E Ratio
–
Div Yield
–%
52W Range
0.91 - 4.20
% vs 50 MA
7.54%
% vs 200 MA
61.95%
RSI-14
47.9
MACD Histogram
-0.0700
Beta (1Y vs SPY)
0.73
Free Cash Flow
-$3.47M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$4.55M
COGS
$0
Operating Exp
$4.56M
Operating Income
-$4.56M
EBIT
-$4.56M
Pretax Income
-$7.31M
Net Income
-$7.31M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Correction: Entera to Participate in Upcoming Fall Investor Conferences
GlobeNewswire · Aug 27, 2026 1:44 PM
Entera to Participate in Upcoming Fall Investor Conferences
GlobeNewswire · Aug 27, 2026 12:00 PM
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
GlobeNewswire · Aug 18, 2026 12:00 PM
Entera Bio Eyes Phase 3 Start for Oral Osteoporosis Drug EB613 After FDA Agreement
MarketBeat · Aug 13, 2026 6:04 PM
Entera Bio shares slip as Q2 loss comes in wider than expected
InvestorsHub · Aug 10, 2026 11:02 AM
Entera Announces Second Quarter 2026 Financial Results and Business Updates
GlobeNewswire · Aug 7, 2026 8:05 PM
Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting
GlobeNewswire · Aug 4, 2026 12:30 PM
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
GlobeNewswire · Jul 31, 2026 8:30 PM
Top Midday Gainers
MT Newswires · Jul 27, 2026 5:48 PM
BC-Most Active Stocks
Associated Press · Jul 27, 2026 2:30 PM
Financial Overview - Income Statement
Quarterly
Mar 2025
See ENTX's money flow as a full page
Social Sentiment
No Reddit posts found for ENTX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.